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Genital tractAbstract Recently, vaccination against sexually transmitted diseases as well as tumor therapy
using new systems such as nanomaterials is a promising strategy. For successful usefulness of mag-
netite nanoparticles (MNPs) in medical applications through the vaginal route, it is essential to
understand their biological fate and cellular toxicity in the animal tissues. This study aims to inves-
tigate the biodistribution, histopathological and immunological impacts of MNPs on in the liver,
spleen and genital tract tissues of female mice after the intravaginal instillation. MNPs were
observed within spleen and liver parenchyma as well as vaginal stroma after 3 days and 2 weeks
of the instillation, and completely cleared from the vaginal stroma tissue after 6 weeks. Splenic lym-
phocytes of treated spleen were characterized with anisokaryosis; anisochromia. Quantitatively, the
number of megakaryocyte and lymphocyte nuclei size in the spleen were highly increased after
instillation of MNPs. MNPs caused acute inﬂammation in the liver and tarsal joints dermal.
Immunologically, MNPs induced the vaginal secretion IgA and Bcl-2 reactivity in the hepatocytes,
the expression of fucose residues and number of BM8+ cells in the genital tract tissues after instil-
lation. Our data indicated that MNPs could inﬂuence the splenic lymphocytes and hepatocytes as
well as the cellular and humoral immune responses in the mice genital tract tissues after 2 weeks of
intravaginal instillation. This information could be useful for avoiding the side effects of MNPs
Histopathological and immunological changes in the spleen, liver and genital tract of mice 33when used in medical applications. Further investigations about the safety and toxicity of MNPs
should be achieved before their use in the medical ﬁeld.
ª 2015 The Egyptian German Society for Zoology. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Sexually transmitted diseases such as HIV and Herpes have
become extremely widespread all over the world especially in
England (Hughes and Field, 2015). In addition to the sexually
transmitted diseases, genital tract tumors such as uterine and
cervical tumors also have been appeared as the main diseases
facing women in the world. Therefore, ﬁnding the suitable sys-
tems for successful vaccination against sexually transmitted
diseases or tumor therapy is the main goal for researchers
nowadays. Nanotechnology is one of the most effective sys-
tems used to overcome these diseases. It is a promising new
ﬁeld with potential applications in the biological and biomed-
ical ﬁelds (Nakamura et al., 2012, 2013). In the biomedical
applications, the nanomaterials were applied into the animal
model tissues through several routes such as oral, intravenous,
or subcutaneous routes, etc. Recently, nanomaterials were
used a lot for several applications as vaccine delivery using
the vaginal route (Whaley et al., 2010). The most studied nano-
materials with promising potential in the ﬁeld of biomedical
applications are those with magnetic properties (Prodan and
Ciobanu, 2013). Recently, Fe3O4 magnetite nanoparticles
(MNPs) have been widely used for biological applications,
such as magnetic resonance imaging therapy (Yallapu et al.,
2011), in hyperthermia tumor therapy (Hayashi et al., 2013),
in drug delivery systems (Ansari et al., 2014) and molecular
detection of biomarkers in biological cells (Haun et al.,
2011). It is crucial to widely study the biological toxicity and
fate of MNPs to ensure their safety for biological and medical
applications. Previously, there was no detailed study that
revealed the biological abnormalities or biodistribution caused
by MNPs after intravaginal instillation. In a literature, after
3 weeks of intravenous administration of MNPs (193 nm),
serum iron levels gradually increased for up to 1 week but
levels slowly declined thereafter. Also, MNPs were localized
in the liver and spleen parenchyma more than other tissues
and cleared gradually after 3 weeks of treatment (Jain et al.,
2008). In another study, the biodistribution of intravenously
injected MNPs (5 nm) showed 75% of injected dose was found
in the spleen and liver at 15 min post-injection. Moreover,
24% of the MNPs remain in liver after 48 hrs post-injection
(Shanehsazzadeh et al., 2013). Consequently as reported by
Briley-Saebo et al. (2004) MNPs were distributed equally in
both liver endothelial and Kupffer cells but not liver parench-
yma following intravenous injection in rats. Previous studies
also did not reveal any detailed results about biodistribution
and fate of MNPs after the intravaginal instillation.
Previously, quantum dots and PLGA NPs were observed in
the draining lymph nodes and female genital tract tissues after
intravaginal instillation (Ballou et al., 2012; Cu et al., 2011).
After 2 days of intraperitoneal injection of MNPs (10 nm),
the liver showed nuclei atrophy and vacuolar degeneration in
hepatocytes. Also, the spleen showed an increase in the mono-
cyte number with chromatin irregularities in the spleniclymphocytes (Prodan and Ciobanu, 2013). Contradictory,
after intravenous injection, MNPs (193 nm) did not show
any histological abnormalities in the liver, spleen after 7 days
of treatment (Jain et al., 2008; Kim et al., 2005). The dose
and size of injected NPs can affect the cellular and tissue tox-
icity in vivo and in vitro. After 2 weeks of intravenous injection
of higher dose of titanium dioxide NPs (40 nm), the liver
showed hepatocyte degeneration, multifocal lesions, spotty
necrosis of liver hepatocytes and portal lymphocyte inﬁltra-
tions (Xu et al., 2013; Alariﬁ et al., 2013). In vitro exposure
to high concentrations of anionic MNPs results in a dose-
dependent diminishing viability and capacity of PC12 cells
(Pisanic et al., 2007). Further, MNPs (15 nm, 30 nm) were
intravenously injected into mice at a dose of 5 mg/kg, MNPs
were not cleared after 1 month and the liver enzymes elevated
after 1 month post-injection (Gu et al., 2012). Also, after
2 weeks of oral administration of zinc oxide NPs (120 nm),
mice had dose–effect pathological damages in the stomach,
liver, heart and spleen (Wang et al., 2008). Moreover, dose-
dependent caused some liver damage after 28 days of oral
administration of 300 mg of silver NPs (60 nm) (Kim et al.,
2008). Titanium dioxide NPs caused splenocyte apoptosis
and cytoplasmic vacuolar degeneration after intraperitoneal
injection into the mice (Abdel Aziz and Awaad, 2014).
In the past few years, there was no clear study to investigate
the cellular and humoral immune responses induced by MNPs
especially after intravaginal instillation. Intravenous adminis-
tration of MNPs increased the number of CD4+ and CD8+
T lymphocytes, interleukin-2, interferon-c, and interleukin-10
in peripheral blood after 72 h as compared with control
(Chen et al., 2010). Moreover, organosilica NPs (100 nm)
increased the number of CD11b+ macrophages and IgA+ cells
in the sub-epithelial domes of Peyer’s Patches after oral admin-
istration. Furthermore, organosilica NPs (925 nm) induced the
expression of fucose residues and mucosal IgA on the surface
of M cells in the follicle-associated epithelia of Peyer’s Patches
and increased the number of 33D1+ dendritic cells in the sub-
epithelial domes of Peyer’s Patches.
However, most of previous studies did not elaborate on the
different toxicological impacts of MNPs. In this study, mice
were treated intravaginally with MNPs for 3 days, 2 weeks
and 6 weeks. Mainly, the liver and spleen are the most targeted
organs by MNPs or other nanomaterials after intravenous
treatment (Hayashi et al., 2013). Additionally, iron has higher
afﬁnity to accumulate in the human joints (Nishiya et al.,
2003). The direct absorption of MNPs from the genital tract
also can affect the immune responses in the genital tract of
treated mice. Therefore, the purpose of this study is to evaluate
the uptake and biodistribution of MNPs in the liver, spleen
and vaginal tissue after intravaginal instillation.
Additionally, the detailed cellular and tissue toxicity as well
as cellular and humoral immune responses of MNPs were
investigated in these tissues. The uptake, biodistribution and
the toxicological impacts in cells and tissues caused by
34 A. AwaadMNPs in the spleen, liver and tarsal joints skin will be investi-
gated histologically and histochemically. The expression of
fucose residues and macrophage number induction in the gen-
ital tract tissues and Bcl-2 protein reactivity in the liver will be
evaluated immunohistochemically. The induction of IgA anti-
body in the vaginal secretions and liver enzymes titers will be
investigated biochemically. The outcomes from this study
could provide important information about MNPs safety
and toxicity before their important use in the medical applica-
tions such as vaccine delivery against sexually transmitted dis-
eases as well as thermotherapy for genital tract tumors.Materials and methods
Preparation and characterization of MNPs
Preparation of MNPs
MNPs were prepared according to previous reported proce-
dures with some modiﬁcations (Hayashi et al., 2008). Brieﬂy,
iron(III) acetylacetonate (1.75 mmol) (Sigma–Aldrich
Chemical Co., UK) was dissolved in 25 ml ethanol. A mixture
of hydrazine monohydrate (7 mmol), (Sigma–Aldrich
Chemical Co., UK) and (70 mmol) water dissolved in 8.3 ml
ethanol was added to the iron(III) acetylacetonate solution
mixture at room temperature. The reaction mixture was incu-
bated at 80 C for 12 h. Then, the reaction mixture was cen-
trifuged, sonicated, washed, and ﬁnally, a black solid
precipitation was obtained.Figure 1 (a): Light microscope image showing the aggregations of M
(c): The MNPs size distribution using the DLS.Characterization of MNPs
The shape and size distribution of the MNPs were investigated
under the TEM. The general size range of the MNPs was mea-
sured using the TEM ﬁgures. The dynamic light scattering
(DLS) was used to analyze the size distributions of MNPs
(Nicomp Particle Sizing Systems, Santa Barbara, California)
at the room temperature. The average size of the MNPs was
conﬁrmed again using Image J software.
Intravaginal instillation of MNPs
Adult female white mice (Mus musculus), 14 weeks old, were
used for this study. All experiments are carried out according
to the guidelines for the Care and Use of Animals approved by
Animal Experiments Committee in Sohag University. Animals
were separated into 4 groups for this experiment; each group
containing 7 mice, 6 mice were studied in each group. This
experiment was achieved during the diestrus phase in each
female mouse. Animals were kept in cages in the animal house
under the normal conditions of a 12:12-h light:dark cycle,
25 C room temperature and free access to water and food.
The estrous stages of mice were determined by analyses of
vaginal lavage cells and vaginal appearance (Byers et al.,
2012; McLean et al., 2012). MNPs were sonicated to reduce
their aggregation and checked under light microscope before
instillation (Fig. 1a). Then, using ﬁne tips, vaginal lumen
was washed several times with phosphate buffer saline (PBS)
for vaginal lavage cytology examination. A dose of 1.7 g
Fe/kg was used in this experiment. This dose is enough toNPs. (b): Transmission electron microscope image showing MNPs.
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within 2 days (Huang and Hainfeld, 2013). Therefore, in this
study 15 mg/dose (115 ll of 130 mg/ml) of prepared MNPs
was instilled intravaginally. Each mouse received 3 doses (total
45 mg/mouse), one dose each 12 h during diestrous stage. The
control group intravaginally instilled with PBS and the other 3
groups were left for about 3 days, 2 weeks and 6 weeks after
MNPs instillation.
During diestrous stage, all mice were sacriﬁced by cervical
dislocation. The liver, spleen, genital tract tissues (vagina,
uterus) and tarsal joints skin were collected and kept in 4%
paraformaldehyde for cryosections and in Carnoy or Bouin’s
solutions for parafﬁn sections. Serial parafﬁn and cryosections
(7 lm) were cut and used for light microscope and ﬂorescence
imaging respectively.
Biodistribution of MNPs in the spleen, liver and vaginal tissue
Parafﬁn sections (7 lm) of the spleen, liver and vaginal tissue
of all groups were sectioned from the parafﬁn blocks andFigure 2 Light microscope images of the spleen (a–h) and liver (i–p
after intravaginal instillation. For the spleen, (a, e): control spleen, MN
pulp (bold arrows). (b, f): After 3 days, MNPs were observed clearly in
pulp (bold arrows). (c, g): After 2 weeks and (d, h): after 6 weeks, MN
heads) and white pulp (bold arrows) but not in the red pulp (arrows). F
within hepatic strands. (j, n): After 3 days, MNPs (arrows) were obse
2 weeks and (l, p): after 6 weeks, MNPs were observed clearly within he
white pulp; RP: red pulp; F: follicle; MZ: marginal zone; HPV: hepa
d) = 10 lm; (i–l) = 10 lm; (m–p) (enlarged of i–l) = 5 lm.afﬁxed to glass slides. Sections then were deparafﬁnized in
xylene and hydrated through descending concentrations of
ethanol and washed in distilled water. Prussian blue stain (mix-
ture of 2% HCl and 2% potassium ferrocyanide) is a highly
sensitive method for identifying iron in the tissues. Some
hydrated sections were immersed in a freshly prepared
Prussian blue solution, heated for 10 s at 60 C in microwave
then solution cooled at room temperature for 30 min. Slides
then were washed, dehydrated, and cleared in xylene.
Dehydrated and cleared tissue sections were mounted in
DPX mounting media, allowed to dry overnight at room tem-
perature and observed under light microscope (Axio Lab.A1,
Carl ZEISS, Germany) equipped with AxioCamERc5s
camera.
Histological examinations
For histopathological study, some parafﬁn sections of the
spleen, liver, tarsal joints skin were selected for this study.
Hydrated parafﬁn sections of 7 lm in thickness were stained) stained with Prussian blue stain showing MNPs biodistribution
Ps were observed in traces in the spleen white pulp (arrows) and red
the spleen red pulp (arrows) and with small amount in the white
Ps were observed clearly within the follicle marginal zone (arrow
or the control liver, (i,m): MNPs (arrows) were observed in traces
rved within hepatic strands but with small amount. (k, o): After
patic strands (arrows) and within hepatic portal veins (asters). WP:
tic portal veins. Scale bar: (a–d) = 50 lm; (e–h) (enlarged of a–
36 A. Awaadwith hematoxylin and eosin, mounted in DPX, and observed
under light microscope.
B-cell lymphoma 2 (Bcl-2) proinﬂammatory protein reactivity
detection
To identify the Bcl-2 proteins reactivity, the hydrated parafﬁn
sections were incubated with the blocking buffer (PBS/0.1%
Tween 20 + 5% bovine serum) for 3 h at room temperature.
After washing with PBS sections were incubated for 2 h with
rabbit anti-Bcl-2 antibody (1:100 or 0.01 mg/ml) (Sigma–
Aldrich Chemical Co., UK) at room temperature. After wash-
ing three times, the sections were incubated in biotin-
conjugated goat anti-rabbit IgG for 2 h at room temperature,
washed PBS three times, incubated for 1 h in ABC complex at
room temperature and then visualized with a chromogen solu-
tion that contained 0.05% 30,30-diaminobenzadine. Stained
sections then mounted with DPX mounting media and investi-
gated under light microscope.
Immunohistochemical observations of female genital tract tissues
Paraformaldehyde ﬁxed cryo-sections from vaginal tissue and
uterus were embedded in optimal cutting media, kept in
80 C. Then the cryo-blocks were cut using cryostat microtome
into 7 lm serial sections, washed in PBS, blocked in the bovine
serum albumin for 1 h in 4 C. Some sections were incubated
with anti-F4/80 antibody (BM8) FITC conjugated
(0.05 lg/mL) (Sigma–Aldrich Chemical Co., UK) for over-
night to identify the distribution of macrophages in the vaginal
and endometrial tissues. Other sections were incubated in Ulex
europaeus agglutinin I (UEA I) FITC conjugated (20 lg/mL)
for 4 h at 4 C to identify the fucose residue expression inFigure 3 Light microscope images of vaginal epithelium and stroma
MNPs biodistribution after intravaginal instillation. (a): Control vagina
in the vaginal stroma (arrows) as well as in the vaginal lumen (arrow
stroma similar to those after 3 days (arrows). (d): After 6 weeks, MNP
compared with those after 3 days or 2 weeks. VE: vaginal epithelium;the vaginal and endometrial tissues. Sections then washed
three times in PBS, mounted and then sections were observed
under ﬂuorescence microscope (Axio Scope.A1, Carl ZEISS,
Germany) equipped with AxioCamERc5s camera.Quantitative analysis of the histological and
immunohistochemical observations
Some representative histological images were selected from
each tissue for the quantitative analysis of the histological
and immunological changes caused by MNPs using software.
The percentage of the Prussian blue area representing MNPs
in the spleen, liver as well as vaginal stroma was estimated in
11 represented Prussian blue stained slides (n= 11). The total
area used for this estimation from the spleen as well as liver
was 0.25 ± 0.012 mm2. The nucleus size of lymphocytes in
white and red pulp of the spleen was measured in 9 represented
hematoxylin and eosin stained slides (n= 9). The number of
megakaryocytes in the spleen and liver was counted in 8 repre-
sented hematoxylin and eosin stained slides (n= 8). The total
area used for this estimation from the spleen as well as liver
was 0.25 ± 0.012 mm2. The number of hair follicles and seba-
ceous glands in the tarsal joint skin were counted in 6 repre-
sented hematoxylin and eosin stained slides (n= 6). The
thickness of the epidermis and dermis layers in the tarsal joint
skin was measured in 6 represented hematoxylin and eosin
stained slides (n= 6). The line length of the skin used for tar-
sal skin estimation was 1614 ± 210 lm. For the immunologi-
cal impacts, the number of BM8+ cells in both vaginal
epithelium and endometrial stroma was calculated in 13 repre-
sented immunostained slides (n= 13). The total area used for
the immunological impacts from vaginal epithelium as well as
endometrial stroma was 0.22 ± 0.013 mm2.with higher magniﬁcation stained with Prussian blue stain showing
l epithelium and stroma. (b): After 3 days, MNPs were clearly seen
heads). (c): After 2 weeks, MNPs were seen clearly in the vaginal
s were seen in the vaginal stroma with a small amount (arrows) as
VS: vaginal stroma; VL: vaginal lumen. Scale bar: (a–d) = 10 lm.
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Vaginal secretions IgA induction
Vaginal secretions from each group after MNPs instillation
were collected using a ﬁne tip and PBS and used for SDS–
PAGE and Western blotting. A suitable and equal amount
from protein standard (10 lg) and vaginal secretion for each
group (15 lg) was applied on the sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS–PAGE). Proteins on
the gel were electrophoretically transferred to the polyvinyli-
dene diﬂuoride (PVDF) membrane, incubated in mouse anti
IgA antibody conjugated with FITC (11 lg/ml, 1:100 dilution)
(Sigma–Aldrich Chemical Co., UK), and scanned under ﬂuo-
rescence Typhon scanner 9400, GE Healthcare, (Tokyo,
Japan). The IgA band density was measured, analyzed by
ImageQuant TL software, Amersham Biosciences Corp,
(Piscataway, USA). The IgA value in the vaginal secretions
was calculated from the means of IgA densometric mea-
sures ± standard deviation (n= 3–5).Figure 4 Light microscope images of the spleen (a–h) and liver (i–p)
impacts after MNPs intravaginal instillation. For the spleen, (a, e): C
white pulp, red pulp, and marginal zone. (b, f): After 3 days, there wa
2 weeks the borders of spleen follicle were not the same with the contro
(d, h): After 6 weeks, there was no clear spleen follicle, higher number o
was marginal and vacuolated (arrows). The erythrocytes were found
headed arrows) but not after 6 weeks. For the liver, (i, m): in control
(aster). (j, n): After 3 days little vacillations start to appear (arrow head
inﬁltration (bold arrows), severe vacuolar degenerations (arrow he
degeneration of the nucleus of some hepatocytes (arrows), and the de
white pulp; RP: red pulp; F: follicle; MZ: marginal zone; MK: megaka
Scale bar: (a–d) = 50 lm; (e–h) = 5 lm; (i–l) = 50 lm; (m–p) = 5 lmSerum ALT and AST assays
Blood serum from each mice group was collected for the bio-
chemical analysis. Liver enzymes, alanine aminotransferase
(ALT) and aspartate aminotransferase (AST) were detected
in blood serum of mice using UV–VIS spectrophotometer,
UV2300 (Techcomp Limited, Shanghai, China). The number
of mice of each group engaged in this experiment was ﬁve mice
(n= 5).
Results
MNP preparation and characterizations
Before administration the MNPs into the mice their aggrega-
tions were sonicated very well using and checked under the light
microscopy (Fig. 1a). The TEM data of the MNPs showed its
formation under the preparation condition we used. The size
of theMNPswas brieﬂy ﬁrst calculated underTEM.The generalstained with hematoxylin and eosin stain showing the histological
ontrol spleen showing intact and distinct spleen follicle with clear
s no a remarkable change of the spleen architecture. (c, g): After
l and megakaryocytes started to increase in number (arrow head).
f megakaryocytes (arrow heads), the splenic lymphocyte chromatin
obviously within splenic cords after 3 days and 2 weeks (double
liver hepatic strands were intact with normal hepatic portal vein
s). (k, o): After 2 weeks there was appearance of portal lymphocyte
ads). (l, p): After 6 weeks, there were hepatocyte atrophy and
generation hepatic portal veins wall (double headed arrows). WP:














38 A. Awaadsize of MNPs was ranged from 7.2 nm as the smaller size to
16.5 nmas the largest size (Fig. 1b).Using the highermagniﬁca-
tions of MNPs TEM photos as well as Image J software the size
of prepared MNPs was 13.4 ± 3.2 nm in diameter. In addition
to the TEM observation, the data of the DLS showed relatively
narrow size distribution of the MNPs with 15% of the standard
deviation (Fig. 1c).gure 5 Digital camera and light microscope images stained with
stopathological impacts after 6 weeks of MNPs intravaginal instillation
e mice tarsal joints without abnormal morphological changes. (b): A his
d dermis, clear hair follicle (bold arrows), and large adipose layer. (
ntaining hair follicle and sebaceous gland (arrow). (d): A digital ca
travaginal instillation showing marked swelling of the tarsal joints. (e):
MNPs intravaginal instillation. Instead of the adipose layer there wa
ere were several large and small vacuoles (asters) indicating dermal ed
as degenerated and small in number. (f): Magniﬁcation 1, the dermis
agniﬁcation 2, sebaceous gland (arrows) were several and large in size.
: tarsal joint; EpD: epidermis; D: dermis; HF: hair follicle; AdL: adipo
r: (b, e) = 100 lm; (d, f, g, h) = 10 lm.Biodistribution of MNPs in the spleen, liver and vaginal tissue
To determine the histological and immunological impacts of
the prepared MNPs after intravaginal instillation, we investi-
gated the biodistribution of MNPs. As shown in Fig. 2 the
Prussian blue stain is the speciﬁc stain for the detection of iron
species in tissues. In the control spleen (Fig. 2a, e) a trace ofhematoxylin and eosin showing mice tarsal joint skin and
. As shown of the control images, (a): a digital camera image of
tological image of the tarsal region skin showing intact epidermis
c): Higher magniﬁcation, showing intact epidermis and dermis
mera image of the mice tarsal joints after 6 weeks of MNPs
Histopathological impacts in the tarsal region skin after 6 weeks
s a new tissue composed from lymphocyte follicle aggregation.
ema, with hydropic degeneration. The hair follicle (bold arrows)
was degenerated and containing several vacuoles (asters). (g):
(h): Magniﬁcation 3, lymphocyte follicle with some ﬂuid inside.
se layer; SG: sebaceous gland; LyFs: lymphocytes follicles. Scale
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arrows) and red pulp (arrows). After 3 days (Fig. 2b, f)
MNPs were observed clearly in the spleen white pulp (bold
arrows) and with a small amount in the spleen red pulp
(arrows). After 2 weeks (Fig. 2c, g) MNPs migrated and
aggregated in the spleen white pulp (bold arrows) and a small
amount kept in the spleen red pulp (arrows). Some faint blue
stain from MNPs was aggregated within the spleen follicle
marginal zone (arrow heads). After 6 weeks (Fig. 2d, h)
MNPs were gradually cleared from both spleen white pulp
(bold arrows) as well as red pulp (bold arrows) but some faintFigure 6 Light microscope images of the liver stained with anti-Bcl
intravaginal instillation. (a, e): Control, there was high expression of B
portal veins (arrow heads). (b, f): After 3 days the expression of Bcl-2
arrows). (c, g): After 2 weeks the expression of Bcl-2 proteins was rest
veins (arrows). (d, h): After 6 weeks the Bcl-2 immunoreactivity was
(arrow heads). HPV: hepatic portal vein. Scale bar: (a–d) = 100 lm; (blue stain remained in the follicle marginal zone (arrow heads).
These data indicated that, MNPs can stay in the spleen, espe-
cially follicle marginal zone, for more than 6 weeks. Also, the
biodistribution and clearance of MNPs in the spleen regionally
differ according to the time.
As for the control liver (Fig. 2i, m), traces of MNPs were
observed within the hepatic strands (arrows) but not within the
hepatic portal veins (aster). After 3 days (Fig. 2i, n) MNPs
were observed clearly within the hepatic strands (arrows).
But after 2 weeks (Fig. 2k, o) MNPs aggregated more within
the hepatic strands as compared with that after 3 days (arrows)-2 antibody showing the expression of Bcl-2 protein after MNPs
cl-2 proteins in hepatocytes (bold arrows) and around the hepatic
proteins was restricted only on the few nests of hepatocytes (bold
ricted faintly only on some hepatocytes around the hepatic portal
negative in all the hepatic tissues except hepatic portal veins wall
e–h) = 10 lm.
40 A. Awaadand appeared with a small amount in the hepatic portal veins
(aster). Then, after 6 weeks (Fig. 2l, p), Prussian blue stain
was faint indicating the clearance of MNPs from the hepato-
cytes (arrows) and the stain increased in the hepatic portal vein
(aster). These data of the liver illustrated that, MNPs stay
within the hepatic strands up to 6 weeks, and then it was accu-
mulated in the hepatic portal system and decreased gradually
from the hepatic parenchyma.
As a conﬁrmation of the spleen and liver data we investi-
gated the biodistribution of the MNPs in the vaginal tissues
as shown in Fig. 3. After 3 days of MNPs instillation I
observed the MNPs in the vaginal stroma clearly as well as
in the vaginal lumen (Fig. 3b). After 2 weeks of instillation
MNPs were also seen in the vaginal stroma similar to that after
3 days (Fig. 3c). The MNPs were completely cleared from the
vaginal stroma after 6 weeks of instillation (Fig. 3a), similar to
that of the control (Fig. 3a). The data of the MNPs biodistri-
bution and clearance from the vaginal tissues conﬁrm the data
of the spleen and liver.Figure 7 Fluorescence microscope images stained with UEA I (U
expression in vaginal tissue (a–h) and uterine tissue (i–p) after MNPs
residues were not expressed in the vaginal epithelium. (b, f): After 3 d
2 weeks, a-L fucose residues were expressed clearly on the vaginal epith
the vaginal stroma (arrow heads). (d, h): After 6 weeks a-L fucose resid
similar to that after 2 weeks. For the uterus (i, m): control and (j, n):
endometrial stroma or in the endometrial epithelium or in the uterine
found in the endometrial stroma. (l, p): After 6 weeks, the a-L fucos
arrows) and uterine glands (aster). VE: vaginal epithelium; EnE: endom
h) = 10 lm; (i–l) = 50 lm; (m–p) = 10 lm.Histopathological impacts caused by MNPs in spleen and liver
parenchyma
The normal spleen (Fig. 4a, e) architecture composed mainly
the white pulp including the marginal zone and the red pulp,
which is completely different in their structure and cellular
types from the white pulp. There were no obvious histological
changes in the spleen architecture after 3 days of MNPs instil-
lation (Fig. 4b, f). But, after 2 weeks (Fig. 4c, g) spleen folli-
cle was not distinct as much as that of normal spleen. The
hematoxylin stain afﬁnity of the splenic lymphocytes after
2 weeks of instillation decreased compared with that of nor-
mal. The megakaryocytes in the treated spleen slightly
increased in number after 2 weeks of the instillation (arrow
heads). Consequently, after 6 weeks (Fig. 4d, h) there were
severe histological impacts in the spleen, the spleen architec-
ture was deformed, there was neither distinct white pulp nor
marginal zone. The megakaryocyte highly increased in number
as compared with that of control (arrow heads). Spleniclex europaeus agglutinin I) marker showing a-L fucose residue
intravaginal instillation. For the vagina, (a, e): control, a-L fucose
ays some UEA I+ cells were observed (arrow heads). (c, g): After
elium (bold arrows) and there was large number of UEA I+ cells in
ues were expressed clearly on the vaginal epithelium (bold arrows)
after 3 days a-L fucose residues were not expressed either in the
glands. (k, o): After 2 weeks several numbers of UEA I+ cells was
e residues expressed clearly on the endometrial epithelium (bold
etrial epithelium; UG: uterine gland. Scale bar (a–d) = 50 lm; (e–
Histopathological and immunological changes in the spleen, liver and genital tract of mice 41lymphocytes were characterized with mild anisokaryosis;
anisochromia, mild acidophilic cytoplasm, condensed chro-
matin, and blebbing nuclei as compared with normal splenic
lymphocytes (arrow). The erythrocytes were found obviously
within splenic cords after 3 days and 2 weeks but not after
6 weeks. These data of spleen indicated that MNPs caused
light toxicological impacts after 2 weeks and severe toxicolog-
ical impacts after 6 week of the instillation. Additionally, the
safety period of MNPs to stay in mice spleen was approxi-
mately lesser than 1 month.
Liver as well as spleen were affected with presence of MNPs
within the hepatic strands. After 3 days of instillation
(Fig. 4j, n) the hepatocytes showed slightly vacuolar degener-
ation (arrow head), the structure of the portal area (aster) was
still clear, no clear lymphocyte inﬁltration was observed but
slightly basophilic hepatocytes were observed as compared
with normal liver (Fig. 4i, m). Then, after 2 weeks
(Fig. 4k, o), there was higher portal lymphocyte inﬁltrationFigure 8 Fluorescence microscope images stained with anti-F4/80 (
uterine tissue (i–p) after MNPs intravaginal instillation. For the vagin
base of the vaginal epithelium (bold arrows) as well as in the muscularis
to increase and aggregate on the surface and base of the vaginal epithe
aggregations within the vaginal epithelium and on the surface (bold ar
the number slightly decreased as compared with that of 2 weeks. For t
endometrial stroma but neither in the endometrial epithelium nor uteri
were found in the endometrial stroma and uterus lumen and the numbe
slightly decreased in the endometrial stroma. VE: vaginal epithelium;
gland; UL: uterus lumen. Scale bar (a–d) = 250 lm; (e–h) = 50 lm; ((bold arrows), severe vacuolar degeneration (arrow heads)
and highly basophilic cytoplasm of hepatocytes as compared
with normal. Additionally, there were no distinct hepatic lob-
ules as compared with that of control. After 6 weeks we
observed an increase in the liver size, some hepatic lobules
were obvious and anisokaryosis (arrows), mild acidophilic
cytoplasm, anisochromia, granular cytoplasmic degeneration,
mild apoptosis hepatocytes, and portal wall degeneration
(double headed arrows) were also observed. These data of
the liver indicated that, vascular degeneration and lymphocyte
inﬁltration of the liver were observed earlier than those of the
spleen. Additionally, the safety time of MNPs to stay in the
mice liver was approximately lesser than two weeks.
Histopathological and morphological impacts in tarsal joint skin
For the morphological impacts of mice, the tarsal and carpal
joints in the control mice appeared ﬂexible with normal ﬁngersBM8) antibody showing BM8+ cells in vaginal tissue (a–h) and
a, (a, e): Control, BM8+ cells were distributed on the surface and
layer (arrow heads). (b, f): After 3 days BM8+ cell number started
lium (bold arrow). (c, g): After 2 weeks, BM8+ cells made nests of
rows). (d, h): After 6 weeks BM8+ cells start to dis-aggregate and
he uterus, (i, m), control, BM8+ cells were rarely expressed in the
ne glands. (j, n): After 3 days and (k, o): after 2 weeks BM8+ cells
r slightly increased. (l, p): After 6 weeks, the number of BM8+ cells
Mu: muscularis layer; EnE: endometrial epithelium; UG: uterine
i–l) = 250 lm; (m–p) = 50 lm.
Figure 9 (a): Western blotting analysis of the IgA induction in
the vaginal secretions showing higher induction of IgA after
6 weeks of MNPs vaginal instillation. (b): Quantities analysis of
the IgA density IgA induction after 6 weeks was 6 times higher as
compared with control. (c): A graph showing the levels of the
alanine aminotransferase (ALT) and aspartate aminotransferase
(AST) in the blood serum of mice after intravaginal administration
of MNPs. The liver enzymes increased after 2 weeks of the
injection and thereafter returned back to the normal. Each value
represents the mean ± standard error of ﬁve mice (n= 5).
42 A. Awaadand paws. After 3 days and 2 weeks of instillation there were
no morphological abnormalities in the mice groups
(Fig. 5a). After 6 weeks, 3/4 of mice group have morphologi-
cal abnormalities in the tarsal and carpal joints ranging from
mild to severe changes. Affected mice could not walk perfectly
and had swelling in the tarsal and carpal joints, redness and
hairless skin, ankle movement restriction and ﬁnger and paw
deformation. These morphological abnormalities resemble
those of the induced arthritis (Fig. 5d).
The histological features of the normal tarsal joint skin
showed intact epidermis with multi-cellular layers, intact der-
mis and large subcutaneous layer (Fig. 5b). Additionally, the
dermis has several hair follicles with low number of sebaceous
glands (Fig. 5c, bold arrows). There were no histological
impacts in the tarsal joint skin after 3 days and 2 weeks (data
not shown). After 6 weeks of MNPs instillation, tarsal joint
skin has severe histological abnormalities (Fig. 5e). The epi-
dermis showed large number of cell layers (Fig. 5g). The der-
mal layer was degenerated, characterized with large and small
vacuoles, higher thickness as compared with that of control
(Fig. 4e, f, asters). The hair follicles were degenerated, lost
hair roots, decreased in the number as compared with control.
Moreover, sebaceous glands were characterized with large size
and higher number as compared with that in control (Fig. 5g,
arrows). As unexpected results, there was an unknown tissue
under the dermis; this tissue had lymphocyte inﬁltrations, lym-
phocyte follicle aggregation with hydropic degeneration and
ﬂuid vacuoles (Figs. 5e, g and 4f). These data indicate that,
MNPs are able to produce direct or indirect severe histological
impacts in the tarsal joint skin after 6 weeks.
Bcl-2 proinﬂammatory protein reactivity in the liver tissue
The Bcl-2 proinﬂammatory protein reactivity was studied
using anti-Bcl-2 antibody immunostaining. In the normal liver
Bcl-2 protein was highly expressed in hepatocytes as well as the
hepatic portal wall and blood sinusoids (Fig. 6a, e). After
3 days, the expression of the Bcl-2 proteins sharply decreased
and restricted only on some hepatocytes (bold arrows) and
hepatic portal wall had faint stain (arrow heads)
(Fig. 6b, f). Then, after 2 weeks, Bcl-2 did not express at all
in all hepatocytes except some hepatocytes surrounding the
hepatic portal wall (Fig. 6c, g, arrows). After 6 weeks there
was no expression of the Bcl-2 protein neither in the hepato-
cytes and faintly expressed in the hepatic portal wall (arrow
heads) (Fig. 6d, h). These data indicate that, intravaginal
instillation of MNPs could change the expression of Bcl-2 pro-
tein in the hepatocytes due to the induction of apoptosis in the
hepatocytes especially after 2 weeks.
Fucose residue expression changes in the genital tract tissues
We investigated the expression changes of the fucose residues
in the female genital tract tissue after MNPs instillation using
lectin UEA I histochemistry. In the normal vaginal tissue
(Fig. 7a, e) as well as after 3 days of instillation (Fig. 7b, f)
there was no expression of a-linked fucose residues in the vagi-
nal tissues. But, after 2 weeks, fucose residues were expressed
on the tips of the vaginal epithelium (bold arrow) as well as
on some cells in the vaginal stroma (arrow heads)
(Fig. 7c, g). After 6 weeks (Fig. 7d, h), fucose residueexpression was the same as that after 2 weeks. The expression
of the fucose residues in the uterine tissues in the control
(Fig. 7i, m) as well as after 3 days was negative (Fig. 7j, n).
The same with that in the vaginal tissue, fucose residues were
expressed on some cells in the endometrial stoma (arrow
heads) but not on the endometrial epithelium after 2 weeks
(Fig. 7k, o). After 6 weeks fucose residues were expressed
only on the endometrial epithelium (bold arrow) as well as
the uterine gland epithelium (aster) (Fig. 7l, p). These data
illustrate that, MNPs could titer the expression of fucose resi-
dues in both vaginal epithelium and endometrial stroma and
epithelium after 2 weeks of the intravaginal instillation.
Induction of fucose residue expression in the vaginal and
endometrial tissues indicated the induction of immune system
by MNPs.
BM8+ cells immune responses in the genital tract tissues
The immune responses in the female genital tract after MNPs
intravaginal instillation were investigated using the anti-F4/80

















































































































































































































































































































































































































































































































































































































































Histopathological and immunological changes in the spleen, liver and genital tract of mice 43tissue expressed BM8+ cells with small number scattering in
the vaginal epithelium as well as in the vaginal stroma and
muscularis (Fig. 8a, e, bold arrows). After 3 days of instilla-
tion (Fig. 8b, f) BM8+ cells were observed on the tips and
under the vaginal epithelium (bold arrows). The number of
the BM8+ cells slightly increased in the vaginal epithelium
as compared with that of control. After 2 weeks, the BM8+
cells were aggregated in groups on the tips and under the vagi-
nal epithelium. The number of BM8+ cells in the vaginal
epithelium was signiﬁcantly higher than that of control or after
3 days. Furthermore, the number of BM8+ cells in the vaginal
stroma and muscularis slightly increased as compared with
that of control (Fig. 8c, g, arrow heads). The BM8+ cell num-
ber in the vaginal epithelium after 6 weeks of instillation was
high as much as that after 2 weeks (Fig. 8d, f). These data
of the BM8+ cell number increase indicating highly cellular
immune responses in the vaginal epithelium after MNPs
intravaginal instillation.
As for the uterus, BM8+ cells were not clearly observed
either in the endometrial stroma or epithelium in the normal
uterus (Fig. 8i, m). After 3 days, BM8+ cells were observed
with small numbers in the uterine lumen and in the endome-
trial stroma (Fig. 8j, n, bold arrows). The number of BM8+
cells slightly increased in the endometrial stroma as compared
with that after 3 days (Fig. 8k, o). There were no signiﬁcant
changes of the BM8+ cell numbers between that after 2 weeks
and 6 weeks (Fig. 8l, p). These data indicate that, the cellular
immune response in the uterus was not as much as that in the
vagina even after 6 weeks.
Biochemical analysis
Vaginal secretions IgA induction
As shown in Fig. 9a, b; using the western blotting investiga-
tions MNPs instillation through the vaginal route could induce
the vaginal secretions IgA after 3 days of instillation (Fig. 9a).
Quantitatively as compared with control the IgA induction
after 3 days and 2 weeks was 3 times and 4 times respectively
higher and 6 times higher after 6 weeks (Fig. 9b). These data
indicated that the presence and uptake of MNPs with the vagi-
nal tissue could titer the humoral immune responses such as
IgA.
Serum ALT and AST assays
As shown in Fig. 9c and Table 1, the blood serum AST and
ALT were detected using the biochemical analysis. The AST
and ALT levels in serum increased after 2 weeks of MNPs
injection and thereafter decreased. These data indicate that
MNPs could inﬂuence the liver function within two weeks
but thereafter, and after clearance of MNPs liver function
returns as that of control.
Quantitative analysis of the histological images
Using representative images of the histological, histochemical
and immunohistochemical studies we quantitatively evaluated
the exact and reliable impacts of MNPs after intravaginal
instillation. The biodistribution and uptake of MNPs in the
spleen, liver as well as vaginal stroma were quantitatively eval-
uated as shown in Fig. 10a. The percentage of iron species in
the vaginal stroma after 3 days and 2 weeks was signiﬁcantly
Figure 10 A graph showing the quantitative analysis of the histological and immunohistochemical images after MNPs intravaginal
instillation. (a): The percentage of the Prussian’s blue area representing the iron species in 0.25 ± 0.012 mm2 of the spleen, liver and
vaginal stroma. The iron species in the vaginal stroma were signiﬁcantly increased after 3 days and 2 weeks and cleared after 6 weeks as
compared with control. The iron species in the spleen signiﬁcantly increased after 3 days, 2 weeks, and 3 weeks as compared with control
and slightly increased in the liver (n= 11). (b): The nucleus size of lymphocytes in both white pulp and red pulp, the nucleus size slightly
increased after 6 weeks (n= 9). (c): The number of megakaryocytes in 0.25 ± 0.012 mm2 of the spleen and liver, the megakaryocyte
number increased signiﬁcantly after 6 weeks as compared with control, there was no change in the megakaryocyte number of the liver
(n= 14). (d): The size of the epidermis and dermis in 1614 ± 210 lm length of the tarsal joints skin (n= 6). The size of the dermis was
signiﬁcantly increased after 6 weeks as compared with control; there was no signiﬁcant change in the epidermis size in all samples. (e): The
number of the hair follicle and sebaceous gland in 1614 ± 210 lm length of the tarsal joint skin (n= 6). The number of the hair follicle
decreased clearly after 6 weeks, but the number of the sebaceous gland increased signiﬁcantly after 6 weeks as compared with control. (F):
The BM8+ cell number in 0.22 ± 0.013 mm2 of the vaginal and uterine tissues, the number of BM8+ cells signiﬁcantly increased after
2 weeks and 6 weeks of injection as compared with control (n= 13).
44 A. Awaadhigher as compared with control. After 6 weeks the percentage
of MNPs was similar to that of control indicating the clearance
of MNPs from vaginal stroma. The percentage of MNPs in the
spleen after 2 weeks, 6 weeks was 4 times was higher than that
of control. Also, the percentage of the MNPs in the liver after
2 weeks, 6 weeks was 3 times higher as compared with that of
control. Moreover, the percentage of the MNPs in the spleen
was signiﬁcantly higher than that in the liver.
There were no signiﬁcant changes in the lymphocyte’s
nucleus size in spleen white pulp and spleen red pulp afterMNPs instillation. There was a slight increase of the lympho-
cyte’s nucleus size after 6 weeks of the instillation (Fig. 10b).
Moreover, the number of the megakaryocytes in the spleen
was signiﬁcantly 5 times higher than that of control after
6 weeks of MNPs instillation. Also, there was no signiﬁcant
change in the number of megakaryocytes in the liver after
MNPs instillation (Fig. 10c). The thickness of the tarsal joint
skin dermis was 2 times higher than that of control after
6 weeks of MNPs instillation. There were no signiﬁcant
changes in the epidermis thickness after MNPs instillation
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decreased 3 times lower than that after 6 weeks of MNPs instil-
lation. Also, the number of the sebaceous glands in the dermis
increased 3 times higher after 6 weeks of the instillation as
compared with that of control (Fig. 9e). The number of
BM8+ cells in vaginal epithelium was signiﬁcantly 13 times
higher after 2 weeks and 6 weeks as compared with that of con-
trol. Also, there were no signiﬁcant changes of the BM8+ cell
number in the endometrial stroma after MNPs instillation
(Fig. 10f). Moreover, the number of BM8+ cells in the vaginal
epithelium was signiﬁcantly higher than that in endometrial
epithelium after MNPs instillation. These quantitative data
conﬁrm and gave our histological data their reliability.
The signiﬁcant impacts caused by MNPs after intravaginal
instillation also, are summarized in Table 1. The uptake of
MNPs in the spleen and vaginal stroma after 3 days and
2 weeks was signiﬁcantly higher than that of control. Also,
the megakaryocyte number in the spleen and tarsal skin dermis
thickness were signiﬁcantly higher than that of control.
Moreover, after 6 weeks of instillation the number of hair fol-
licle in tarsal skin dermis decreased signiﬁcantly as compared
with control. The sebaceous glands in tarsal skin dermis
increased signiﬁcantly after 6 weeks of instillation. The reactiv-
ity of the Bcl-2 proteins in the liver decreased signiﬁcantly after
2 and 6 weeks. The BM8+ cells in the vaginal epithelium were
signiﬁcantly increased after 2 and 6 weeks of the instillation as
compared with that of control.Discussion
Recently, nanomaterials were used in a wide range of applica-
tions such as, biology, medicine, chemistry, or electronics and
so on. Nanomaterials can be produced from several chemical
sources. These chemicals have potential environmental risks
especially, on the animal or even human. Nanotechnology
was developed to minimize the potential risks of the used
chemicals. The exposure to the prepared nanomaterials signif-
icantly increased in the last 10 years. This is because nanoma-
terials can be used mainly in the food quality improvement and
in the drug delivery systems (Ensign and Wang, 2012;
Mallipeddi and Rohan, 2010). Therefore, it is important to
introduce detailed information about the safety of any nano-
materials before used in the medical applications.
In this study MNPs were instilled intravaginally during the
diestrus stage. Rats and mice typically have a 4–6 day cycle
which consists of 4 stages, proestrus, estrus, metestrus, diestrus
(Sengupta, 2011). Diestrus is the longest stage lasting more
than 2 days, and histologically characterized with absence of
stratum corneum and thin stratum germinativum with non-
squamous epithelium (Rehm et al., 2007). The histological
and physiological features of diestrus stage render it as the
most suitable stage for our study. In the normal spleen and
liver traces of the iron species were observed in their parench-
yma and this iron might be come from food containing iron or
metal materials from the animal cages. After 3 days of MNPs
intravaginal instillation we observed some MNPs in the spleen
red pulp, within liver parenchyma and in the vaginal stroma.
MNPs start to be cleared from spleen red pulp, liver parench-
yma and vaginal tissues after 2 weeks. Very few studies about
the biodistribution and uptake of nanomaterials were investi-
gated after intravaginal instillation. Previously afterintravaginal instillation PLGA NPs were taken up by the vagi-
nal epithelium cells, accumulated in the sub epithelial stroma
of the vagina (Cu et al., 2011). Moreover, quantum dots
entered the draining lymph nodes after 36 h from intravaginal
instillation (Ballou et al., 2012). Our data introduce a step for-
ward for these previous studies, i.e. MNPs could be observed
in the spleen, liver as well as vaginal tissues after intravaginal
instillation.
In this study also, after 3 days and 2 weeks of the intravagi-
nal instillation of MNPs (13 nm), there was no remarkable
change in the spleen architecture. But after 6 weeks, the spleen
architecture was deformed; i.e. there was no distinct follicle.
Furthermore, higher number of megakaryocytes, and splenic
lymphocytes characterized with marginal and vacuolated chro-
matin were observed. Moreover, the red blood cells were
clearly reduced after 6 weeks of instillation. In accordance with
this study, after intraperitoneal injection of MNPs (10 nm), the
monocyte number in the spleen red pulp increased, and they
characterized with nuclear contour irregularities. The discreet
anisochromia with focal chromocenter formation were also
remarked in the splenic pulp after intraperitoneal injection
(Prodan and Ciobanu, 2013). Similar to the impacts caused
by MNPs in this study, titanium dioxide (40 nm) cased multi-
focal lesions in the liver after 2 weeks of the intravenous injec-
tion (Xu et al., 2013). Contradictory, MNPs (193 nm) after
intravenous injection, did not show any histological abnormal-
ities in the spleen after 7 days (Jain et al., 2008; Kim et al.,
2005). This might be because the size, dose and surface func-
tionalization have an important role in the uptake, biodistribu-
tion, toxicity of nanomaterials in tissues (Awaad et al., 2012a;
Kim et al., 2012). Additionally, megakaryocytes are specialized
cells responsible for the production of blood cells and platelets
(Josefsson et al., 2011). The increased number of megakary-
ocytes explains the reduction of the red blood cells after
6 weeks of MNPs instillation.
This study also showed some changes in the liver architec-
ture 2 weeks after intravaginal instillation of MNPs. There was
portal lymphocyte inﬁltration, vacuolar degeneration and
basophilic cytoplasm of hepatocytes as compared with that
of control. The AST and ALT levels in blood serum elevated
after 2 weeks and thereafter down regulated to the normal
level. The normal level of AST and ALT is due to the clearance
of the effecter i.e. MNPs. The mechanism of lymphocyte
appearance in the hepatic parenchyma was due to a chemical
interaction of MNPs with some molecules in the liver parench-
yma and this produces reactive oxygen species, which induces
the inﬂammatory responses in the liver (Johar et al., 2004). The
swelling in the hepatocytes after 6 weeks of MNPs instillation
might be seen as a result of distortion of the hepatocyte plasma
membrane function, leading to sodium and water pinocytosis
due to the effects of NPs. Cell atrophy might be accompanied
by lysosomal activity, leading to vacuolar degeneration of the
hepatocyte cytoplasm (Del Monte, 2005).
A severe impact was observed in this study; the tarsal joints
have some inﬂammations 6 weeks after MNPs instillation. The
morphological changes in the tarsal joints were similar to the
symptoms of induced arthritis in mice (Ernst et al., 2001;
Horai et al., 2000). Histopathologically, the dermal layer in
the tarsal joint skin was highly degenerated, vacuolated and
with atrophy as compared with that of control. The hair folli-
cles were degenerated and hair root numbers decreased as
compared with that of control. Moreover, sebaceous glands
46 A. Awaadwere characterized with atrophy higher number as compared
with that in control. Abnormally, an unknown tissue was
observed under the dermis, this tissue characterized with lym-
phocyte inﬁltrations, lymphocyte follicle aggregation with
hydropic degeneration with lymphatic ﬂuids and vacuoles sur-
rounding the follicle. These abnormalities caused in the tarsal
joints might be explained by two hypotheses: in the ﬁrst
hypothesis MNPs caused disturbance in the animal immune
system such as cytokine or chemokine inductions. These
immune responses could increase the reactivity of the tarsal
joint epithelial cells with these molecules. The interleukin 1
family (IL-1) is one member of cytokines, which has important
function in the control of immune and inﬂammatory responses
to infections or foreign pathogens. The IL-1family plays an
important function in the regulation of the pathophysiology
of rheumatoid arthritis and tarsal joints arthritis can be pro-
duced by the inhibition of IL-1 family (Horai et al., 2000;
Kay and Calabrese, 2004). The second hypothesis is, the
decomposition of MNPs in the tissues increased the iron spe-
cies in the blood, and accumulated in the animal joints and
caused inﬂammatory implications. Previously, infusion of iron
activated synovial membrane, induced joint inﬂammation and
induced arthritis in patients with rheumatoid arthritis (Nishiya
et al., 2003). Moreover, iron has an important role in rheuma-
toid arthritis synovitis through the formation of radical oxygen
species, and the collagen synthesis and synovial ﬁbroblast pro-
liferation (Nishiya, 1994). More data are needed to explain the
two mechanisms of tarsal joint inﬂammations caused by
MNPs in the future work.
This study showed also a reduction of the Bcl-2 pro-
inﬂammatory proteins reactivity in the hepatocytes 2 weeks
after instillation. Moreover, BM8+ macrophage number in
the vaginal epithelium was signiﬁcantly increased 2 weeks after
MNPs instillation. In addition to the macrophage number
increase, fucose residues in vaginal and uterine epithelium were
highly expressed 2 weeks after instillation as compared with
the control. Also, IgA in the vaginal secretion was induced
after 2 weeks and 6 weeks of the vaginal instillation of
MNPs. These data indicate that MNPs could inﬂuence
immune responses of the normal mice similar to previous stud-
ies (Awaad et al., 2012b; Chen et al., 2010; Mu¨ller et al., 2007;
Thomas et al., 2009). Moreover, Bcl-2 protein is a cytoprotec-
tive response that counteracts pro-apoptotic and pro-
inﬂammatory insults in the cells (Badrichani et al., 1999).
Also, fucose residues are important cell surface carbohydrate
that have important roles in immune responses against patho-
gens (Becker and Lowe, 2003). The induction of the mucosal
IgA in the vaginal lumen by the presence of MNPs in this
study is similar with our data published previously. The uptake
of 100 nm organosilica particles increased the number of
CD11b+ macrophages and IgA+ cells in Peyer’s Patches.
Additionally, 925 nm organosilica particles induce the expres-
sion of the fucose residues on the surface of M cells in Peyer’s
Patches as well as mucosal IgA on the surface of M cells
(Awaad et al., 2012b). Furthermore, higher dose of intra-
venously injected MNPs caused immunological abnormalities
such as, T cell number increase, induction of interleukin-2,
interferon-c, and interleukin-10 in blood serum (Chen et al.,
2010). Additionally, MNPs slightly affected viability of the
macrophages in vitro (Mu¨ller et al., 2007).
In this study, the intravaginal instillation of MNPs caused
both the histopathological and immunological changes in thenormal mice after 2 weeks of instillation.
Histopathologically, MNPs caused distortion in the spleen
architecture. The treated splenic lymphocytes characterized
with anisokaryosis; anisochromia and moderate acidophilic.
The number of megakaryocytes highly increased 6 weeks after
instillation in the spleen. In the liver MNPs caused higher por-
tal lymphocyte inﬁltration, vacuolar degeneration of liver par-
enchyma with basophilic cytoplasm of hepatocytes.
Immunologically, MNPs caused cellular and humoral
immunological abnormalities such as IgA induction in the
vaginal secretion, reducing the reactivity of BCL-2 proinﬂam-
matory proteins in the liver, inducing the expression of fucose
residues in the genital tract and increasing the number of
macrophages in the genital tract of mice. Biochemically,
MNPs elevated the liver enzymes such as AST and ALT after
2 weeks of instillation. Understanding the potential abnormal-
ities associated with exposure to MNPs used in a great variety
of medical and biological applications is crucial. It is very
important to design functionalized MNPs compatible with tis-
sues that can be effectively internalized and meet the demands
of particular applications without producing cellular toxicity.Acknowledgments
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